Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 5Other hematologic neoplasm 5Myeloid 2Lymphoid 2

Conditions

Myelodysplastic Syndromes 425Leukemia, Myeloid, Acute 351Leukemia 240Leukemia, Myelogenous, Chronic, BCR-ABL Positive 232Precursor Cell Lymphoblastic Leukemia-Lymphoma 211Myeloproliferative Disorders 161Lymphoma, Non-Hodgkin 156Hodgkin Disease 135Primary Myelofibrosis 129Leukemia, Lymphocytic, Chronic, B-Cell 129Multiple Myeloma 126Leukemia, Myelomonocytic, Chronic 118Lymphoma 106Leukemia, Myeloid, Chronic-Phase 78Lymphoma, Mantle-Cell 76Lymphoma, Follicular 71Congenital Abnormalities 69Blast Crisis 69Lymphoma, Large B-Cell, Diffuse 67Leukemia, Myeloid, Accelerated Phase 66Polycythemia Vera 64Lymphoma, B-Cell, Marginal Zone 64Burkitt Lymphoma 63Hematologic Neoplasms 53Anemia, Refractory, with Excess of Blasts 52Lymphoma, Large-Cell, Immunoblastic 51Neoplasms, Plasma Cell 47Myelodysplastic-Myeloproliferative Diseases 44Thrombocythemia, Essential 40Recurrence 40

Interventions

Cyclophosphamide 2thymoglobulin 1plerixafor 1fludarabine phosphate 1fludarabine 1aldesleukin 1Thiotepa 1Tacrolimus 1Rituximab 1Mycophenolic Acid 1Melphalan 1Interleukin-2 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cytarabine 1Clofarabine 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Sarcoma, Myeloid × Myeloid × Clear all
NCT02259348 2017-05-30

Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation

St. Jude Children's Research Hospital

Phase 2 Terminated
12 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Sarcoma, Myeloid, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT01621477 2017-02-20

T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

St. Jude Children's Research Hospital

Phase 2 Terminated
34 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Sarcoma, Myeloid, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡